2024-11-14T19:39:21-06:00 2023-12-31 LUCY XIA CPA 7283 PASEO CAPUCHINA CARLSBAD CA 92009 990EZ 2023-01-01 731627787 SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS SOCA 4127216167 PO BOX 927631 SAN DIEGO CA 921927631 WENJUN FAN CFO 4127216167 2024-11-14 1 0 X LUCY XIA P00783763 8586998838 X 2023 2024-10-15 13:58:12Z X X X HTTP://SABPA.ORG X X 186695 X 7298 164128 10815 4454 186695 7568 128671 9 36512 172760 13935 372978 0 386913 X 370977 384640 2001 2273 372978 386913 0 0 372978 386913 X SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS(SABPA)'S MISSIONS ARE: (A). TO PROVIDE A FORUM TO FACILIATE PROFESSIONAL CONTACT AND COMMUNCATION AMONG LOCAL PROFESSIONALS IN ACADEMIA, BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES; (B). TO FOSTER PROFESSIONAL GROWTH, CAREER IMPROVEMENT AND PERSONAL DEVELOPMENT OF OUR MEMBERS; (C). TO PROVIDE OPPORTUNITIES TO EDUCATE LOCAL COMMUNITIES ABOUT THE VALUE OF BIOMEDICAL RESEARCH AND THE BENEFITS OF BIOTECHNOLOGY AND PHARMACEUTICAL INNOVATIONS; (D). TO STIMULATE AND FACILIATE THE DEVELOPMENT OF RELATIONSHIPS GLOBALLY IN BIOTECHNOLOGY AND PHARMACEUTICAL COMMUNITIES. The 7th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum (February 4, 2023)The 7th FTD Forum was held on February 4, 2023 at Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CA. It covered the latest progress in neurodegenerative and psychiatric diseases, and COVID-19 drug development and diagnosis. This year the Forum was in person with two concurrent breakout sessions covering the hottest topics. The audience had great opportunities to ask questions, share ideas, learn from the experts, and network with their peers.Program highlights are as follows:1. Neurodegenerative diseases and drug development2. Psychiatric diseases and translational research3. Anti-Covid drug development4. Long Covid effects on brain5. Post-Covid diagnosis 0 50849 The 21st San Diego BioPharma Conference was held at Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CA on September 30, 2023. For the past 20 years, San Diego BioPharma Conference, the flagship event of the organization, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation's premier innovation centers. From potential Nobel laureates and technologically disruptive inventors to entrepreneurs and multi-billion-dollar dealmakers, this annual conference has been featuring some of the most respectful figures in the fields. This year, the long-awaited in-person conference is back.Program highlights are as follows:1. Academia pioneers in protein misfolding and neurodegeneration2. Biotech leaders in CART, antibody therapy, autoimmune disease and fibrosis3. Story behind a successful acquisition4. Innovative bio-platform to bring new therapies to patients5. Integrated drug discovery platform for global medical industry6. Venture capital financings, mergers and acquisitions trends7. Licensing, building and managing strategic alliances8. Startup building in venture funded incubator9. Build a global clinical-stage biotech focused on immunology-related area 0 109613 OTHER EVENTS (i.e. eCorner, educational career development in Bio-field, etc.) were held during the year 0 10497 170959 X STEPHANIE SHI BOARD MEMBER 1.00 0 0 0 MINGZHU ZHANG BOARD MEMBER 1.00 0 0 0 WEIJUN SHEN BOARD MEMBER 1.00 0 0 0 JC XU BOARD MEMBER 1.00 0 0 0 JIAN LIU BOARD MEMBER 1.00 0 0 0 YI LIU BOARD MEMBER 5.00 0 0 0 ANDREW WANG BOARD MEMBER 1.00 0 0 0 HUAINA LI BOARD MEMBER 1.00 0 0 0 YANG LIU BOARD MEMBER 1.00 0 0 0 TRACEY YEO BOARD MEMBER 1.00 0 0 0 ZHEN ZHU BOARD MEMBER 1.00 0 0 0 PENGYU YANG BOARD MEMBER 1.00 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CA WENJUN FAN PO BOX 927631 SAN DIEGO CA 92192 4127216167 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 2506 52256 23978 7898 18113 104751 2506 52256 23978 7898 18113 104751 104751 148 146 14 665 4454 5427 110178 560628 0.95070 0.98910 X Form 990-EZ, Part I, Line 4 - Other Investment Income Description: INTEREST INCOME. Amount: 4454. Form 990-EZ, Part I, Line 14 Description: Depreciation. Amount: 5638. Description: Other Expenses. Amount: 123033. Total to Form 990-EZ, line 14: 128671. Form 990-EZ, Part I, Line 16 - Other Expenses Description: OFFICE SUPPLIES. Amount: 3119. Description: MANAGEMENT MEETING EXPENSES. Amount: 18046. Description: ADVERTISING AND MARKETING PROMOTIONS. Amount: 600. Description: BANK CHARGES. Amount: 2169. Description: INSURANCE. Amount: 1606. Description: PROGRAM EVENT EXPENSES. Amount: 7469. Description: PROFESSIONAL DUE. Amount: 1702. Description: GENERAL ADMINISTRATIVE EXPENSE. Amount: 1000. Description: Depreciation. Amount: 801. Total to Form 990-EZ, line 16: 36512. Form 990-EZ, Part II, Line 24 - Other Assets Description: Other Depreciable Assets. Beg. of Year Amount: 2001. End of Year Amount: 2273. The organization did not, during the year, receive any funds, directly,or indirectly, to pay premiums on a personal benefit contract.The organization, did not, during the year, pay any premiums, directly,or indirectly, on a personal benefit contract.